| Filed On | Filing |
|---|---|
| 03 Jun 2024 |
Form 4: Viking Global Investors Lp, 10% owner and 7 others
Disposed of 7,150,826 shares (Other Transaction) ($215M) · Disposed of 1,038,765 Warrants (right to buy) (Other Transaction) ($31.2M) |
| 31 May 2024 |
Form 4: Inhibrx, Inc., 10% owner · Inhibrx Biosciences Inc
Disposed of 13,316,140 shares (Other Transaction) |
| 30 May 2024 |
Form 4: Vuori Kristiina Md, Director
Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Manhard Kimberly, Director
Disposed of 65,759 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Lappe Mark, Director
Returned 3,045,654 shares to the issuer ($91.4M) · Disposed of 245,000 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Kayyem Jon Faiz, Director
Returned 3,274,301 shares to the issuer ($98.2M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Forsyth Douglas, Director
Returned 598,257 shares to the issuer ($17.9M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Eckelman Brendan P., Chief Scientific Officer
Sold 300,000 shares ($10.3M) · Returned 2,055,553 shares to the issuer ($61.7M) · Disposed of 33,334 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Disposed of 45,000 Stock Option (right to buy) (Disposition to Issuer) |
| 24 May 2024 |
Form 4: Eckelman Brendan P., Chief Scientific Officer
Exercised 5,010 Stock Option (right to buy) ($171K) |
| 08 May 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 19,711 Stock Option (right to buy) ($675K) |
| 28 Mar 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 2,896 Stock Option (right to buy) ($103K) |
| 22 Mar 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 16,777 Stock Option (right to buy) ($588K) · Exercised 3,113 Stock Option (right to buy) ($109K) · Exercised 110 Stock Option (right to buy) ($3.85K) |
| 15 Mar 2024 |
Form 4: Eckelman Brendan P., Chief Scientific Officer
Exercised 1,898 Stock Option (right to buy) ($67.1K) |
| 15 Mar 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 32,431 Stock Option (right to buy) ($1.15M) |
| 12 Mar 2024 |
Form 4: Eckelman Brendan P., Chief Scientific Officer
Exercised 2,150 Stock Option (right to buy) ($76.9K) · Exercised 13,558 Stock Option (right to buy) ($479K) · Exercised 24,050 Stock Option (right to buy) ($848K) |
| 12 Mar 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 42,523 Stock Option (right to buy) ($1.52M) |
| 06 Mar 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Exercised 62,083 Stock Option (right to buy) ($2.2M) · Exercised 10,417 Stock Option (right to buy) ($372K) |
| 30 Aug 2023 |
Form 4: Viking Global Investors Lp, 10% owner and 5 others
Bought 511,627 shares ($9.9M) · Acquired 1,038,765 Warrants (right to buy) (Open Market Purchase) ($20.1M) |
| 30 May 2023 |
Form 4: Forsyth Douglas, Director
Granted 15,000 Stock Option (right to buy) |
Loading...